QR-Code

Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives

Aim. To evaluate the efficacy of the antiviral drug riamilovir (trade name – «Triazavirin®») for the prevention of SARS-CoV-2 infection (COVID-19) and other acute respiratory viral infections in young people from organized groups. Materials and methods. The study involved 386 individuals aged 18–...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Konstantin V. Kozlov, Oleg V. Maltsev, Kristina V. Kasyanenko, Vitalii S. Sukachev, Andrei V. Saulevich, Sergey S. Karyakin, Alexey D. Dubrovin, Roman N. Smirnov
Format: Artigo
Sprache:Russo
Veröffentlicht: "Consilium Medicum" Publishing house 2024-12-01
Schriftenreihe:Терапевтический архив
Schlagworte:
acute respiratory viral infections
acute respiratory diseases
riamilovir
nucleoside analogues
prevention
Online-Zugang:https://ter-arkhiv.ru/0040-3660/article/viewFile/637437/pdf
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge